Zegerid OTC, Private Label Omeprazole Add Drug Interaction Warnings
This article was originally published in The Tan Sheet
Executive Summary
CDER approves sNDAs from Bayer for Zegerid OTC powder and private label manufacturer Dexcel Pharma for omeprazole delayed release tablets to add label warnings on drug-drug interactions for methotrexate and mycophenolate mofetil.